Drug Status Key

  • Preferred
  • On Formulary
  • Specialist Initiation
  • Shared Care
  • Hospital Only
  • Under Review
  • New on System

2.8.1 Parenteral anticoagulants

Notes:

  1. The use of antiplatelet therapy, thrombolytics and anti-thrombin treatment in patients with unstable angina and NSTEMI are covered in NICE CG 94: Unstable angina and NSTEMI
  2. Bivalirudin is indicated for the treatment of STEMI in patients undergoing PCI when used in accordance with NICE TA 230: Bivalirudin for the treatment of STEMI (Jul 2011)
  3. Guidance for the prevention of VTE in patients admitted to hospital is detailed in NICE CG 92:Venous thromboembolism - reducing the risks 
    Prophylaxis for VTE prevention
    should continue for 14 days post knee revision and 35 days post hip revision.
  4. NICE CG 144: The management of venous thromboembolic diseases gives guidance on the care of adults with VTE  
  5. Approved dosing regimens for Angiox (bivalirudin) for PCI following reports of inappropriate use. See Direct Healthcare Professional Communication January 2013

 

Please note, sample information has been entered into Chapters 1 and 2 only and although fairly clinically accurate, it is not guaranteed. The information was entered during April and May 2017 and drugs will have subsequently been randomly added during telephone demonstrations.

Show All

Pack Price
10 pre-filled disposable injection £72.30
Pack Price
10 pre-filled disposable injection £20.86
Pack Price
10 pre-filled disposable injection £30.27
Pack Price
10 pre-filled disposable injection £39.26
Pack Price
10 pre-filled disposable injection £55.13
Pack Price
10 pre-filled disposable injection £87.93
Pack Price
10 pre-filled disposable injection £99.91
Pack Price
10 pre-filled disposable injection £59.50
2 pre-filled disposable injection
6 pre-filled disposable injection
Pack Price
10 vial £105.66
Pack Price
10 pre-filled disposable injection £62.79